Cellular Biomedicine Group (CBMG) Misses Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Cellular Biomedicine Group (CBMG) Misses Q3 EPS by 1c

Cellular Biomedicine Group Reports Third Quarter 2015 Financial Results and Provides Business Highlights

November 13, 2015 9:21 AM EST

SHANGHAI, China and CUPERTINO, Calif., Nov. 13, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (CBMG or the Company), a biomedicine firm engaged in the development of effective stem cell therapies for degenerative diseases and immunotherapies for cancer, today reported financial results for the quarter ended September 30, 2015 and provided business highlights.

Dr. William Wei Cao, Chief Executive Officer, commented, We achieved pivotal milestones in the third quarter that redefined CBMGs business and strategically positioned the Company as an emerging, bifurcated and world-class immuno-oncology and cell therapy contender with international aspirations through the... More